Meridian Bioscience Reaffirms FY18 Outlook - Quick Facts

(RTTNews) - Meridian Bioscience, Inc. (VIVO) on Tuesday reaffirmed its adjusted earnings guidance for the full-year 2018 in the range of $0.69 and $0.72 per share and net revenues between $209 million and $214 million.

Further, the Board of Directors declared the regular quarterly cash dividend of $0.125 per share for the third quarter ended June 30, 2018, payable on August 20, 2018 to shareholders of record as of the close of business on August 10, 2018.

For the third quarter, the company reported net earnings of $6.83 million or $0.16 per share, up from $0.24 million or $0.01 per share in the prior-year quarter. Adjusted net income for the quarter was $0.18 per share, compared to $0.16 per share in the year-ago quarter.

Net revenue for the quarter grew 3 percent to $51.74 million from $50.14 million in the same quarter last year.